Natera Research and Development Expenses 2014-2024 | NTRA
Natera annual/quarterly research and development expenses history and growth rate from 2014 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Natera research and development expenses for the quarter ending December 31, 2024 were $0.129B, a 56.04% increase year-over-year.
- Natera research and development expenses for the twelve months ending December 31, 2024 were $0.404B, a 26.03% increase year-over-year.
- Natera annual research and development expenses for 2024 were $0.404B, a 26.03% increase from 2023.
- Natera annual research and development expenses for 2023 were $0.321B, a 1.35% increase from 2022.
- Natera annual research and development expenses for 2022 were $0.316B, a 19.76% increase from 2021.
| Natera Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $404 |
| 2023 | $321 |
| 2022 | $316 |
| 2021 | $264 |
| 2020 | $100 |
| 2019 | $51 |
| 2018 | $51 |
| 2017 | $50 |
| 2016 | $42 |
| 2015 | $28 |
| 2014 | $17 |
| 2013 | $12 |
| Natera Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $129 |
| 2024-09-30 | $97 |
| 2024-06-30 | $89 |
| 2024-03-31 | $89 |
| 2023-12-31 | $83 |
| 2023-09-30 | $77 |
| 2023-06-30 | $78 |
| 2023-03-31 | $82 |
| 2022-12-31 | $88 |
| 2022-09-30 | $66 |
| 2022-06-30 | $83 |
| 2022-03-31 | $80 |
| 2021-12-31 | $72 |
| 2021-09-30 | $98 |
| 2021-06-30 | $54 |
| 2021-03-31 | $40 |
| 2020-12-31 | $32 |
| 2020-09-30 | $26 |
| 2020-06-30 | $23 |
| 2020-03-31 | $18 |
| 2019-12-31 | $15 |
| 2019-09-30 | $13 |
| 2019-06-30 | $12 |
| 2019-03-31 | $11 |
| 2018-12-31 | $13 |
| 2018-09-30 | $12 |
| 2018-06-30 | $12 |
| 2018-03-31 | $14 |
| 2017-12-31 | $13 |
| 2017-09-30 | $13 |
| 2017-06-30 | $12 |
| 2017-03-31 | $13 |
| 2016-12-31 | $11 |
| 2016-09-30 | $11 |
| 2016-06-30 | $10 |
| 2016-03-31 | $9 |
| 2015-12-31 | $8 |
| 2015-09-30 | $7 |
| 2015-06-30 | $7 |
| 2015-03-31 | $6 |
| 2014-12-31 | |
| 2014-09-30 | $4 |
| 2014-06-30 | $4 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $21.977B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.427B | 26.15 |
| Elevance Health (ELV) | United States | $93.171B | 12.02 |
| CVS Health (CVS) | United States | $85.832B | 10.67 |
| Cencora (COR) | United States | $55.028B | 19.14 |
| DiDi Global (DIDIY) | China | $20.426B | 31.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.484B | 0.00 |
| Solventum (SOLV) | United States | $11.527B | 12.20 |
| CochLear (CHEOY) | Australia | $11.409B | 0.00 |
| ICON (ICLR) | Ireland | $11.183B | 10.40 |
| Doximity (DOCS) | United States | $11.080B | 57.62 |
| Revvity (RVTY) | United States | $10.950B | 18.84 |
| Viatris (VTRS) | United States | $10.779B | 3.67 |
| Medpace Holdings (MEDP) | United States | $8.646B | 22.96 |
| Avantor (AVTR) | United States | $8.368B | 12.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| HealthEquity (HQY) | United States | $7.900B | 38.86 |
| Charles River Laboratories (CRL) | United States | $6.943B | 13.60 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.064B | 23.96 |
| BrightSpring Health Services (BTSG) | United States | $3.924B | 36.32 |
| Sotera Health (SHC) | United States | $3.755B | 21.34 |
| Alignment Healthcare (ALHC) | United States | $3.051B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.907B | 33.35 |
| Concentras Parent (CON) | United States | $2.706B | 15.64 |
| Organon (OGN) | United States | $2.345B | 2.49 |
| Premier (PINC) | United States | $2.127B | 14.56 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 8.88 |
| Progyny (PGNY) | United States | $2.002B | 44.09 |
| GoodRx Holdings (GDRX) | United States | $1.627B | 30.29 |
| PACS (PACS) | United States | $1.615B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.582B | 61.93 |
| Agilon Health (AGL) | United States | $1.333B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.240B | 9.44 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.004B | 0.00 | |
| CareDx (CDNA) | United States | $0.857B | 13.38 |
| AMN Healthcare Services Inc (AMN) | United States | $0.776B | 7.29 |
| Embecta (EMBC) | United States | $0.773B | 5.30 |
| QDM (QDMI) | Hong Kong, SAR China | $0.674B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.61 |
| Enhabit (EHAB) | United States | $0.491B | 40.38 |
| InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
| LifeMD (LFMD) | United States | $0.371B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.349B | 0.00 |
| SBC Medicals (SBC) | United States | $0.336B | 0.00 |
| DocGo (DCGO) | United States | $0.238B | 38.83 |
| Oncology Institute (TOI) | United States | $0.221B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.176B | 0.00 |
| Beauty Health (SKIN) | United States | $0.155B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |